Financial Press Releases

  • 08/05/2020 ore 09:56
    Friulchem: riconosciuto credito di imposta su costi di IPO per € 339 mila
  • 30/04/2020 ore 19:12
    Il Consiglio di Amministrazione di Friulchem: approva la delibera quadro inerente al contratto di fornitura di materie prime con Evultis e attribuisce deleghe al consigliere Carlo Marelli
  • 23/04/2020 ore 17:32
    Friulchem: Ordinary Shareholders' Meeting approves the Financial Statements as at 31 December 2019
  • 24/03/2020 ore 17:59
    Friulchem: draft financial statements as at 31 December 2019 approved
  • 23/03/2020 ore 12:31
    Coronavirus covid-19 emergency: Friulchem is continuing with production activities
  • 11/03/2020 ore 11:58
    Friulchem grows in the USA and continues its internationalisation process with the acquisition of 13% of Pharmabbie Inc, American company specialised in the development of veterinary drugs to be administered with Friulchem’s FC-CUBE® technology
  • 25/02/2020 ore 17:43
    Friulchem approves the framework resolution regarding the raw materials supply contract with Evultis
  • 20/01/2020 ore 17:05
    2020 Company events calendar
  • 13/12/2019 ore 16:53
    Friulchem approves the transaction with related party
  • 28/11/2019 ore 17:55
    Friulchem approves the framework resolution concerning the contract for the supply of raw materials with Evultis
  • 15/10/2019 ore 07:15
    Friulchem obtains authorization for the marketing in South Africa of an antibiotic for human use with a wide spectrum of action for serious infections

    Friulchem S.p.A. (AIM: FCM), announces that it has obtained, after a "registration process" of over 5 years, the authorization for the marketing in South Africa of a broad-spectrum antibiotic for human use (injectable betalactam belonging to the class of carbapenems for the treatment of serious infections) and to have entered into an agreement with a leading multinational pharmaceutical company - world leader in the distribution of generic drugs - for exclusive distribution in South Africa.

  • 27/09/2019 ore 18:47
    Friulchem continues its internationalization process with the establishment of Friulchem USA Inc.

    Friulchem S.p.A. (AIM: FCM) communicates the constitution of the Friulchem USA Inc. company. The newly company will be active in the marketing and distribution of feed supplement or non-pharmaceutical products for the North American veterinary sector.

  • 27/09/2019 ore 09:30
    CEO at the 2019 semi-annual report

    Disma Giovanni Mazzola, CEO of Friulchem S.p.A. (AIM: FCM) commented on the 2019 half-year figures

  • 26/09/2019 ore 17:55
    Friulchem: the half-year report as of June 30, 2019 approved
  • 29/07/2019 ore 17:58
    SIGNIFICANT SHAREHOLDERS (Available only in Italian)
  • 25/07/2019 ore 18:01
    CORPORATE EVENTS CALENDAR 2019 (Available only in Italian)
  • 23/07/2019 ore 18:37
    NOTIFIED TO CONSOB THE KID - "KEY INFORMATION DOCUMENT" CONCERNING THE "WARRANT FRIULCHEM 2019-2022"
  • 23/07/2019 ore 16:25
    FRIULCHEM S.p.A. ADMITTED TO TRADING ON THE AIM ITALIA MARKET